Author

Charlotte Lynne Bevan

Imperial College LondonORCID 0000-0002-7533-0552Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Microbiology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Damien A. LeachiD· 2 shared Kyle K. GreenlandiD· 2 shared Alastair D.G. LambiD· 1 shared Alice Ormrod· 1 shared Anabel Varela‐Carver· 1 shared Aristotelis A. ChatziioannouiD· 1 shared Ash K. BahliD· 1 shared Chun‐Fui LaiiD· 1 shared

Activity by Year

2023-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Damien A. LeachORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 26, 2025

Chromatin signalling pathways and FANCE amplification affect ATR inhibitor sensitivity in metastatic breast cancer

Jogitha Selvarajah, Rayzel Candida Fernandes, Marc P. Lorentzen…·Charlotte Lynne Bevan

DOI 10.1101/2025.08.26.672363

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 13, 2025

IRE1 activity regulates tumour and microenvironment cell lineage states while stratifying localised and metastatic prostate cancer.

Dimitrios Doultsinos, Ingrid Tomljanović, Eleftherios D. Pilalis…·Ian Geoffrey Mills

This paper identifies IRE1 activity as a regulator of prostate cancer cell lineage states and shows its role in predicting prognosis and treatment response across localized and metastatic disease.

DOI 10.1101/2025.03.13.643042

humanbulk RNA-seq

𝕏 PostBluesky

MicrobiologyJournal of Medical VirologyPeer-reviewedMar 1, 2024

The antiviral potential of the antiandrogen enzalutamide and the viral-androgen interplay in seasonal coronaviruses

Oluwadamilola D. Ogunjinmi, Tukur Abdullahi, Riaz‐Ali Somji…·Efstathios S. Giotis

This study investigates enzalutamide's antiviral effects against seasonal coronaviruses and identifies differences in viral-androgen signaling interactions between HCoV-229E and HCoV-OC43.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky

Molecular BiologyBritish Journal of CancerPeer-reviewedApr 19, 2023

The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer

Theodora A. Constantin, Anabel Varela‐Carver, Kyle K. Greenland…·Charlotte Lynne Bevan

This study investigates the antitumour activity of CT7001, a CDK7 inhibitor, in castration-resistant prostate cancer models, showing it inhibits proliferation and enhances enzalutamide efficacy.

29 citationstop 3%

humanexperimental assay

𝕏 PostBluesky